← Leaderboard
ITCI
Ticker
ITCI
Congressional Trades
6
by 2 members
Ticker Intelligence Brief
Who in Congress traded ITCI, when, and what happened after?
A ticker-first view for retail/data users: latest disclosure, largest range, disclosure lag, party flow, contracts, lobbying, and source-linked receipts.
Latest receipt
Josh Gottheimer
SELL · 2025-04-03
Largest range
$1K – $15K
Josh Gottheimer
Slowest filing
41d
Josh Gottheimer
Best vs SPY
69.4%
Josh Gottheimer
Buys
0
0%
Sells
6
100%
Total Volume
$48K
midpoint
Unique Traders
2
members
Party Breakdown
Democrats6 · 100%
Republicans0 · 0%
Party Trading Divergence
Democrat vs. Republican buy / sell pressure by monthHIGH DIVERGENCEBar length = total trades. Color = net sentiment — green = net buying, red = net selling. Months with no activity hidden.
Democrat ←
Month
→ Republican
0▲1▼
Jun '24
—
0▲1▼
Jan '25
—
0▲2▼
Mar '25
—
0▲2▼
Apr '25
—
Democrats0▲6▼Net sellers
vs
Republicans0▲0▼Neutral
Net buyingNet selling⚡ Party split
💼 Lobbying Filings
all →- 2026-01-16$50KINTRA-CELLULAR THERAPIES INC.Issues related to drug pricing, Medicare reimbursement, implementation of the Inflation Reduction Act, and mental health. H.R. 5376, Impacts and Outcomes for Health Career Training Act.
- 2025-10-16$50KINTRA-CELLULAR THERAPIES INC.Issues related to drug pricing, Medicare reimbursement, implementation of the Inflation Reduction Act, and mental health. H.R. 5376, Impacts and Outcomes for Health Career Training Act.
- 2025-10-10$0INTRA-CELLULAR THERAPIES INC.
- 2025-07-21$10KINTRA-CELLULAR THERAPIES INC.H.R. 1492 - EPIC Act: Provisions regarding harmonizing small and large molecule period in the Inflation Reduction Act.
- 2025-07-21$10KINTRA-CELLULAR THERAPIES INC.Issues related to drug pricing, Medicare reimbursement, implementation of the Inflation Reduction Act, and mental health.
- 2025-04-21$70KINTRA-CELLULAR THERAPIES INC.H.R. 1492 - EPIC Act: Provisions regarding harmonizing small and large molecule period in the Inflation Reduction Act. H.R. 1990 - American Innovation and R&D Competitiveness Act: Provisions regarding Section 174 research and development tax credit amortization.
- 2025-04-21$50KINTRA-CELLULAR THERAPIES INC.Issues related to drug pricing, Medicare reimbursement, implementation of the Inflation Reduction Act, and mental health.
Congressional Momentum
buy vs. sell pressureDISTRIBUTINGScore 0–100: above 50 = net buying pressure, below 50 = net selling. Signal based on last 90 days.
Last 30 Days
No trades
Last 90 Days
No trades
All-Time
▼0
0 buys6 total6 sells
$0 buys · $48K sells
Cumulative Net Position (buy vol − sell vol)
-$48K
2024-066 trades plotted2025-04
Trade Activity Timeline
Congressional buys & sells by month · last 4 months w/ activity
24/06
25/01
25/03
25/04
BuysSellsOtherHigh-volume month
Who Moved First
each row = one member · sorted by earliest disclosed trade0 buyers ·2 sellers
BuySellOtherDot size ∝ trade size · top 2 most-active traders shown
Seasonal Rhythm
Congress buy/sell pressure by month & yearEach cell = one calendar month. Green = net Congress buying, red = net selling. Intensity ∝ consensus strength. Hover for details.
Net buyingNet sellingNo trades · number = trade count
Peak buy month: Jan · Peak sell month: Mar
Congressional Conviction Timeline
net positioning · alpha track recordBEARISH0 buys6 sells4mo tracked
Monthly Net Flow (Buys − Sells)
Alpha data populates as trades are priced — check back once return benchmarks are computed.
All Disclosed Trades
| Date | Member | Action | Amount | Filing Delay | Receipt |
|---|---|---|---|---|---|
| 2025-04-03 | DJosh Gottheimer | SELL | $1K – $15K | 41d | receipt → |
| 2025-04-03 | DGilbert Cisneros | SELL | $1K – $15K | 33d | receipt → |
| 2025-03-17 | DJosh Gottheimer | SELL | $1K – $15K | 24d | receipt → |
| 2025-03-24 | DGilbert Cisneros | SELL | $1K – $15K | 14d | receipt → |
| 2025-01-24 | DJosh Gottheimer | SELL | $1K – $15K | 17d | receipt → |
| 2024-06-21 | DJosh Gottheimer | SELL | $1K – $15K | 18d | receipt → |